Literature DB >> 23694804

Bile salts enhance the intestinal absorption of lipophilic drug loaded lipid nanocarriers: mechanism and effect in rats.

Zhiwen Zhang1, Fang Gao, Shijun Jiang, Lingli Chen, Zeying Liu, Haijun Yu, Yaping Li.   

Abstract

The purpose of this study was to elucidate the effect and possible mechanism of bile salts on the intestinal absorption of lipophilic drug loaded lipid nanocarriers in rats. Effects of sodium cholate (SC) on the characteristics, intestinal absorption, cellular uptake in Caco-2 cell monolayers and intestinal lymphatic transport of candesartan cilexetil loaded lipid nanocarriers (CLN) were investigated to clarify the possible mechanism. The intestinal absorption of candesartan from CLN was evidently improved over 16-fold compared with free drug suspension, and further significantly enhanced 1.79-fold after the addition of SC. The cellular uptake of CLN in Caco-2 cell monolayers at 37̊C and its colocalization with endoplasmic reticulum were obviously increased in the presence of SC. Moreover, the intestinal lymphatic transport of CLN was obviously enhanced by SC. These results implicated that bile salts could improve the cellular uptake of CLN in Caco-2 cell monolayers via the active processes and promote the intestinal absorption of CLN through the intestinal lymphatic pathway. Therefore, bile salts could be an important physiological factor affecting the intestinal absorption of lipophilic drugs loaded lipid nanocarriers.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23694804     DOI: 10.1016/j.ijpharm.2013.05.021

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  11 in total

Review 1.  Bile acid transporter-mediated oral drug delivery.

Authors:  Feiyang Deng; You Han Bae
Journal:  J Control Release       Date:  2020-07-22       Impact factor: 9.776

2.  Anti-inflammatory Effect and Toxicology Analysis of Oral Delivery Quercetin Nanosized Emulsion in Rats.

Authors:  Gabriela Hädrich; Gustavo Richter Vaz; Michelle Maidana; Jadel Muller Kratz; Gecioni Loch-Neckel; Daniely Cornélio Favarin; Alexandre de Paula Rogerio; Flávio Manoel Rodrigues da Silva; Ana Luiza Muccillo-Baisch; Cristiana Lima Dora
Journal:  Pharm Res       Date:  2015-12-18       Impact factor: 4.200

Review 3.  From sewer to saviour - targeting the lymphatic system to promote drug exposure and activity.

Authors:  Natalie L Trevaskis; Lisa M Kaminskas; Christopher J H Porter
Journal:  Nat Rev Drug Discov       Date:  2015-10-16       Impact factor: 84.694

4.  Directed self-assembled nanoparticles of probucol improve oral delivery: fabrication, performance and correlation.

Authors:  Zhiwen Zhang; Shijun Jiang; Zeying Liu; Baohua Niu; Wangwen Gu; Yaping Li; Jingbin Cui
Journal:  Pharm Res       Date:  2014-03-04       Impact factor: 4.200

Review 5.  Multifaceted applications of bile salts in pharmacy: an emphasis on nanomedicine.

Authors:  Yosra S R Elnaggar
Journal:  Int J Nanomedicine       Date:  2015-06-12

6.  Self-microemulsifying drug delivery system for improving the bioavailability of huperzine A by lymphatic uptake.

Authors:  Fang Li; Rongfeng Hu; Bin Wang; Yun Gui; Gang Cheng; Song Gao; Lei Ye; Jihui Tang
Journal:  Acta Pharm Sin B       Date:  2017-02-28       Impact factor: 11.413

7.  Formulation design, characterization, and in vitro and in vivo evaluation of nanostructured lipid carriers containing a bile salt for oral delivery of gypenosides.

Authors:  Gang Yang; Feihua Wu; Minyan Chen; Jian Jin; Rong Wang; Yongfang Yuan
Journal:  Int J Nanomedicine       Date:  2019-04-01

Review 8.  Review of recently used techniques and materials to improve the efficiency of orally administered proteins/peptides.

Authors:  Yousif H-E Y Ibrahim; Géza Regdon; Elnazeer I Hamedelniel; Tamás Sovány
Journal:  Daru       Date:  2019-12-06       Impact factor: 3.117

9.  Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant.

Authors:  Orli Binyamin; Liraz Larush; Kati Frid; Guy Keller; Yael Friedman-Levi; Haim Ovadia; Oded Abramsky; Shlomo Magdassi; Ruth Gabizon
Journal:  Int J Nanomedicine       Date:  2015-11-20

10.  Pharmacokinetics of the P-gp Inhibitor Tariquidar in Rats After Intravenous, Oral, and Intraperitoneal Administration.

Authors:  Peter Matzneller; Manuel Kussmann; Sabine Eberl; Alexandra Maier-Salamon; Walter Jäger; Martin Bauer; Oliver Langer; Markus Zeitlinger; Wolfgang Poeppl
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-10       Impact factor: 2.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.